Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Dai Chihara; Jason R. Westin; Roberto N. Miranda; Chan Y. Cheah; Yasuhiro Oki; Francesco Turturro; Jorge E. Romaguera; Sattva S. Neelapu; Lorreta J. Nastoupil; Luis E. Fayad; M. Alma Rodriguez; Nathan H. Fowler; Robert Z. Orlowski; Michael L. Wang; Fredrick B. Hagemeister; L. Jeffrey Medeiros; Michelle A Fanale

doi:10.1111/bjh.14226

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Dai Chihara, Jason R. Westin, Roberto N. Miranda, Chan Y. Cheah, Yasuhiro Oki, Francesco Turturro, Jorge E. Romaguera, Sattva S. Neelapu, Lorreta J. Nastoupil, Luis E. Fayad, M. Alma Rodriguez, Nathan H. Fowler, Robert Z. Orlowski, Michael L. Wang, Fredrick B. Hagemeister, L. Jeffrey Medeiros, Michelle A Fanale

Research output: Contribution to journal › Article

2 Citations (Scopus)

Original language	English
Pages (from-to)	503-506
Journal	British Journal of Haematology
Volume	179
Issue number	3
DOIs	https://doi.org/10.1111/bjh.14226
Publication status	Published - 2017
Externally published	Yes

Access to Document

10.1111/bjh.14226

Link to publication in Scopus

Cite this

Chihara, D., Westin, J. R., Miranda, R. N., Cheah, C. Y., Oki, Y., Turturro, F., Romaguera, J. E., Neelapu, S. S., Nastoupil, L. J., Fayad, L. E., Rodriguez, M. A., Fowler, N. H., Orlowski, R. Z., Wang, M. L., Hagemeister, F. B., Medeiros, L. J., & Fanale, M. A. (2017). Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. British Journal of Haematology, 179(3), 503-506. https://doi.org/10.1111/bjh.14226

Chihara, Dai ; Westin, Jason R. ; Miranda, Roberto N. ; Cheah, Chan Y. ; Oki, Yasuhiro ; Turturro, Francesco ; Romaguera, Jorge E. ; Neelapu, Sattva S. ; Nastoupil, Lorreta J. ; Fayad, Luis E. ; Rodriguez, M. Alma ; Fowler, Nathan H. ; Orlowski, Robert Z. ; Wang, Michael L. ; Hagemeister, Fredrick B. ; Medeiros, L. Jeffrey ; Fanale, Michelle A. / Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. In: British Journal of Haematology. 2017 ; Vol. 179, No. 3. pp. 503-506.

@article{141484efbe0944a0baeef8201a54f7fa,

title = "Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma",

keywords = "ABVD, EPOCH, Gray-zone lymphoma, Treatment",

author = "Dai Chihara and Westin, {Jason R.} and Miranda, {Roberto N.} and Cheah, {Chan Y.} and Yasuhiro Oki and Francesco Turturro and Romaguera, {Jorge E.} and Neelapu, {Sattva S.} and Nastoupil, {Lorreta J.} and Fayad, {Luis E.} and Rodriguez, {M. Alma} and Fowler, {Nathan H.} and Orlowski, {Robert Z.} and Wang, {Michael L.} and Hagemeister, {Fredrick B.} and Medeiros, {L. Jeffrey} and Fanale, {Michelle A}",

year = "2017",

doi = "10.1111/bjh.14226",

language = "English",

volume = "179",

pages = "503--506",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "3",

}

Chihara, D, Westin, JR, Miranda, RN, Cheah, CY, Oki, Y, Turturro, F, Romaguera, JE, Neelapu, SS, Nastoupil, LJ, Fayad, LE, Rodriguez, MA, Fowler, NH, Orlowski, RZ, Wang, ML, Hagemeister, FB, Medeiros, LJ & Fanale, MA 2017, 'Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma', British Journal of Haematology, vol. 179, no. 3, pp. 503-506. https://doi.org/10.1111/bjh.14226

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. / Chihara, Dai; Westin, Jason R.; Miranda, Roberto N.; Cheah, Chan Y.; Oki, Yasuhiro; Turturro, Francesco; Romaguera, Jorge E.; Neelapu, Sattva S.; Nastoupil, Lorreta J.; Fayad, Luis E.; Rodriguez, M. Alma; Fowler, Nathan H.; Orlowski, Robert Z.; Wang, Michael L.; Hagemeister, Fredrick B.; Medeiros, L. Jeffrey; Fanale, Michelle A.

In: British Journal of Haematology, Vol. 179, No. 3, 2017, p. 503-506.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

AU - Chihara, Dai

AU - Westin, Jason R.

AU - Miranda, Roberto N.

AU - Cheah, Chan Y.

AU - Oki, Yasuhiro

AU - Turturro, Francesco

AU - Romaguera, Jorge E.

AU - Neelapu, Sattva S.

AU - Nastoupil, Lorreta J.

AU - Fayad, Luis E.

AU - Rodriguez, M. Alma

AU - Fowler, Nathan H.

AU - Orlowski, Robert Z.

AU - Wang, Michael L.

AU - Hagemeister, Fredrick B.

AU - Medeiros, L. Jeffrey

AU - Fanale, Michelle A

PY - 2017

Y1 - 2017

KW - ABVD

KW - EPOCH

KW - Gray-zone lymphoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84994160273&partnerID=8YFLogxK

U2 - 10.1111/bjh.14226

DO - 10.1111/bjh.14226

M3 - Article

C2 - 27378601

AN - SCOPUS:84994160273

VL - 179

SP - 503

EP - 506

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -